Crystal structure of crosslink stabilized long-form PDE4B homo-2-mer 166-657
3×ZN; 2×NA; 2×MG; 2×IOD; Assess Crystal structure of crosslink stabilized long-form PDE4B in complex with (R)-(-)-rolipram homo-2-mer 166-657
3×ZN; 2×IOD; 2×ROL; 2×MG; Assess Crystal structure of human phosphodiesterase 4b with regulatory domain and d155988 homo-2-mer 247-658
2×ZN; 2×MG; 2×988; Assess Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with a Quinoline Inhibitor homo-2-mer 325-659
2×SK4; 2×ZN; 2×MG; 6×ARS; 4×GOL; Assess Catalytic domain of human phosphodiesterase 4B2B in complex with a tetrahydrobenzothiophene inhibit… monomer 324-683
1×ZN; 1×MG; 1×HBT; 1×GOL; Assess Crystal structure of phosphodiesterase 4B in complex with compound 31e monomer 326-683
1×NVW; 1×ZN; 1×CA; Assess Crystal structure of phosphodiesterase 4B in complex with compound 10f monomer 326-683
1×QPC; 1×ZN; 1×CA; Assess CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B2B monomer 324-680
1×ZN; 1×MG; 3×ARS; Assess Selective Inhibition of the Catalytic Domain Of Human Phosphodiesterase 4B With A-33 monomer 324-680
1×19T; 1×MG; 1×ZN; 1×NA; 3×EDO; Assess PDE4 catalytic domain monomer 324-680
1×ZN; 1×MG; 1×NA; 1×2O5; 6×EDO; Assess Catalytic Domain Of Human Phosphodiesterase 4B In Complex With (R)-Mesopram monomer 335-685
1×ZN; 1×MG; 1×5RM; Assess Crystal structure of human PDE4b with 5-[3-[(1S,2S,4R)-Bicyclo[2.2.1]hept-2-yloxy]-4-methoxyp henyl… monomer 335-681
1×ZN; 1×0CP; 1×MG; Assess Crystal structure of PDE4B2B complexed with Rolipram (R & S) monomer 324-667
1×ZN; 1×MN; 1×ARS; 1×ROL; Assess CRYSTAL STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHODIESTERASE 4B2B COMPLEXED WITH AMP monomer 324-661
2×ZN; 1×AMP; Assess CRYSTAL STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHODIESTERASE 4B2B COMPLEXED WITH 8-Br-AMP monomer 324-661
2×ZN; 1×8BR; Assess Crystal structure of human phosphodiesterase 4B catalytic domain with inhibitor NPD-001 monomer 323-659
1×ZN; 1×MG; 3×ACT; 1×6M5; Assess Human phosphodiesterase 4B catalytic domain in complex with a pyrrolidinyl inhibitor. monomer 323-658
1×ZN; 1×MG; 1×9VE; Assess Catalytic domain of human phosphodiesterase 4B2B in complex with a quinoline inhibitor monomer 324-659
1×066; 1×ZN; 1×MG; 4×ARS; 3×GOL; Assess Crystal structure of PDE4B catalytic domain in complex with a pyrazolopyridine inhibitor monomer 324-659
1×ZN; 1×MG; 1×20A; 3×ARS; Assess PDE4B bound to MAPI compound 92a monomer 323-658
1×ZN; 1×MG; 1×VL9; Assess Catalytic domain of human phosphodiesterase 4b2b in complex with a 5-heterocycle pyrazolopyridine i… monomer 324-659
1×ZN; 1×MG; 3×ARS; 1×ZG2; 1×GOL; Assess Catalytic domain of human phosphodiesterase 4b2b in complex with a 5-heterocycle pyrazolopyridine i… monomer 325-659
1×ZN; 1×MG; 3×ARS; 1×ZG1; 2×GOL; Assess Crystal structure of PDE4B2B in complex with inhibitor NPV monomer 324-657
1×ZN; 2×MG; 1×NPV; Assess Catalytic Domain of Human Phosphodiesterase 4B in Complex with A Coumarin-Based Inhibitor monomer 324-657
1×Z72; 1×ZN; 1×MG; 1×SO4; Assess Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Roflumilast monomer 327-657
1×ZN; 1×MG; 1×ROF; Assess Crystal structure of human phosphodiesterase 4B (PDE4B) in complex with a [1,3,5]triazine derivative monomer 334-657
1×1S1; 1×MG; 1×ZN; 19×EDO; Assess Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Sildenafil monomer 334-657
1×ZN; 1×MG; 1×SO4; 1×VIA; Assess Human Phospodiesterase 4B in complex with pyridyloxy-benzoxaborole based inhibitor monomer 334-656
1×ZN; 1×MG; 1×6QQ; 17×EDO; Assess PDE4B In complex with ligand an2898 monomer 334-656
1×ZN; 1×MG; 1×3OJ; 14×EDO; Assess Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Filaminast monomer 335-657
1×ZN; 1×MG; 1×FIL; Assess Catalytic Domain Of Human Phosphodiesterase 4B In Complex With AMP monomer 335-657
1×ZN; 1×MG; 1×AMP; Assess Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Cilomilast monomer 335-657
1×ZN; 1×MG; 1×CIO; Assess Catalytic Domain Of Human Phosphodiesterase 4B In Complex With (R,S)-Rolipram monomer 335-657
1×ZN; 1×MG; 2×ROL; Assess Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Piclamilast monomer 335-657
1×ZN; 1×MG; 1×PIL; Assess Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Vardenafil monomer 335-657
1×ZN; 1×MG; 1×VDN; Assess Catalytic Domain Of Human Phosphodiesterase 4B In Complex With 1-(2-chloro-phenyl)-3,5-dimethyl-1H-… monomer 335-657
1×ZN; 1×MG; 1×6DE; Assess Catalytic Domain Of Human Phosphodiesterase 4B In Complex With (R)-Rolipram monomer 335-657
1×ZN; 1×MG; 1×ROL; Assess Catalytic Domain Of Human Phosphodiesterase 4B In Complex With 3,5-dimethyl-1-(3-nitro-phenyl)-1H-p… monomer 335-657
1×ZN; 1×MG; 1×7DE; Assess Crystal structure of N2 substituted pyrazolo pyrimidinones - a flipped binding mode in PDE5 monomer 451-476
1×ZN; 1×MG; 1×3P4; 1×MES; Assess Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with BPN5004 monomer 663-673
2×ZN; 1×MG; 1×E31; 1×CL; Assess